Preventive Antibiotics in Stroke Study (PASS): A cost-effectiveness study

OBJECTIVETo evaluate the cost-effectiveness of preventive ceftriaxone vs standard stroke unit care without preventive antimicrobial therapy in acute stroke patients. METHODSIn this multicenter, randomized, open-label trial with masked endpoint assessment, 2,550 patients with acute stroke were includ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurology 2018-05, Vol.90 (18), p.e1553-e1560
Hauptverfasser:	Westendorp, Willeke F, Zock, Elles, Vermeij, Jan-Dirk, Kerkhoff, Henk, Nederkoorn, Paul J, Dijkgraaf, Marcel G.W, van de Beek, Diederik
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Ceftriaxone - economics Ceftriaxone - therapeutic use Cost of Illness Cost-Benefit Analysis Health Care Costs Humans Middle Aged Quality-Adjusted Life Years Stroke - economics Stroke - therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!